StretchL
Well-known member
I received the following statement from a cardiothoracic surgeon the other day. I'd appreciate any analysis that y'all who are well versed in statistics could provide. My questions- Are this guy's assertions about the linearization of yearly stats valid, and what's the diff between linearized and actuarial. Thanks:
"Note that there is a difference between the actuarial freedom from bleeding or embolism and the linearized incidence of these. The actuarial freedoms are each in the 80% range at 20 years. (Look at the tables carefully to see how many patients are at risk after 20 years - not very many. And at 25 it's almost 0!) However, the annualized linear incidence of anticoagulant-related hemorrhage (ARH) is 2.7%/pt-yr and that for thrombo-embolic phenomena is 1.9%/pt-yr. The simplistic translation of this means there is a 4.6% chance each year for a patient to have one problem or the other. That extrapolates out to over 100% at 25 years, so you can see how realistic is the number of only 25% who have had neither problem by the time they get to 25 years."
This bud's for you, Andyrdj...
"Note that there is a difference between the actuarial freedom from bleeding or embolism and the linearized incidence of these. The actuarial freedoms are each in the 80% range at 20 years. (Look at the tables carefully to see how many patients are at risk after 20 years - not very many. And at 25 it's almost 0!) However, the annualized linear incidence of anticoagulant-related hemorrhage (ARH) is 2.7%/pt-yr and that for thrombo-embolic phenomena is 1.9%/pt-yr. The simplistic translation of this means there is a 4.6% chance each year for a patient to have one problem or the other. That extrapolates out to over 100% at 25 years, so you can see how realistic is the number of only 25% who have had neither problem by the time they get to 25 years."
This bud's for you, Andyrdj...